Skip to content

The Feasibility and Safety of the TOETVA for Benign Thyroid Nodules

A Prospective Evaluation of the Feasibility and Safety of the Transoral Endoscopic Thyroidectomy Vestibular Approach (TOETVA) as a Treatment for Benign Thyroid Nodules

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03158961
Enrollment
10
Registered
2017-05-18
Start date
2017-07-01
Completion date
2019-07-31
Last updated
2021-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Thyroid Diseases

Keywords

Thyroid, Thyroidectomy, Transoral, Endoscopic, Surgery

Brief summary

Thyroid surgery has been developed as a new technique for zero scar in surgery by applying transoral endoscopic thyroidectomy with sublingual approach. The new technique is locating the surgery which pierced through floor of mouth, cause severe tissue damage, high complication, and conversion rates to open surgery and surgical difficulties due to limitation of movement. Nevertheless, each report is still including small number of patients. Recently, the transoral endoscopic thyroidectomy vestibular approach (TOETVA) has been proven feasible and safe in several overseas centers. Moreover, a successful TOETVA case was reported in local media in the late last year. Hence, this study is for evaluating the feasibility and safety of the TOETVA prospectively at a tertiary referral center in Hong Kong. The following are the procedure of the study: 1. Recruit patients from the clinic. 2. Patients will receive treatment within 3 months 3. Patients will have different assessments like Ultrasonography assessment, Fine needle biopsy, Direct laryngoscopy, and Cosmectic scoring in Pre-operation, post-operation 2 week, post 1 month, post 3 month, post 6 month and post 12 month. 4. Patients will be monitoring by the same team after the study.

Interventions

TOVETA is a new approach in surgery of thyroidectomy no longer open on the neck

Sponsors

The University of Hong Kong
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* have a cyst, nodule or a goiter which has been shown to be benign on fine needle aspiration cytology, * need to undergo a unilateral thyroid resection, * have a nodule size no larger than 4cm in largest diameter, * willing to undergo this new approach rather than the traditional open approach.

Exclusion criteria

* unfit for surgery, * has had previous surgery or radiation at the neck, * unable to tolerate a general anesthesia, * wearing dental braces, * absence of vocal cord mobility at laryngoscopy.

Design outcomes

Primary

MeasureTime frameDescription
The complication rate after TOETVA in 12 months12 monthsTo record any complication of surgery in every post-operation visit after 12 months. The record will be used for the calculation of complication rate.

Secondary

MeasureTime frameDescription
The wound infection rate after TOETVA12 monthsTo record the situation of wound infection after surgery
The hematoma rate after TOETVA12 monthsTo record the situation of hematoma after surgery
The vocal cord palsy rate after TOETVA12 monthsTo calculate the vocal cord situation after surgery within 12 months
The open conversion rate of TOETVA12 monthsTo record any cases which need to apply open surgery necessary during the procedure of TOETVA
The pain score of patient after TOETVA12 monthsThe pain scoring with 0-10 to assess the pain level of having TOETVA
The satisfaction of patients after having TOETVA in 12 months12 monthsThe satisfaction in 0-10 scoring after the surgery
The hypoparathyroidism rate after TOETVA12 monthsTo record the thyroid function from blood test in 12 months after surgery and calculate the rate of hypo-parathyroid function

Countries

Hong Kong

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026